Background. Anaplastic thyroid cancer (ATC) is rare, accounting for 1‐2% of thyroid
malignancies. Median survival is only 3‐10 months, and the optimal therapeutic approach …

Purpose To investigate the ultrasonographic (US) features of anaplastic thyroid cancer
(ATC) and the diagnostic performance of US-guided fine needle aspiration biopsy (FNAB) …

Heat shock protein 90 (HSP90) serves as a chaperone protein and plays a critical role in
tumor cell growth and/or survival. Geldanamycin, a specific inhibitor of HSP90, is cytotoxic to …

Most thyroid neoplasms arise from follicular cells and are well differentiated. Anaplastic and
poorly differentiated carcinomas are rare and have a high mortality. Five percent of tumors …

Objective Anaplastic thyroid cancer (ATC) is often unoperable and chemotherapy and
radiotherapy are the main treatments. Until now 'primary ATC cell cultures'(ANA) have been …

Abstracts Anaplastic thyroid cancer (ATC) is a rare but aggressive malignancy of the thyroid.
No effective treatment modalities are currently available. Targeted therapy against protein …

Background Anaplastic thyroid carcinoma (ATC) is the least common but most malignant
thyroid cancer. We aimed to examine the characteristics as well as evaluate the incidence …

Introduction. Anaplastic thyroid carcinoma (ATC) is rare yet accounts for up to 50% of all
thyroid cancer deaths. This study reviews outcomes of patients with confirmed ATC referred …

Background: Anaplastic thyroid carcinoma (ATC) is a rare cancer and has a poor prognosis.
Several radiation protocols have been reported, but the results were not satisfactory …

Background The consequences of super‐radical resection in patients with anaplastic thyroid
carcinoma (ATC) have not been fully investigated. Methods This retrospective study used …